Showing results (41-50 of 89) with videos related to
Sort By:
Pageof 9
The Journal of Urology|October 19, 1999
A computer generated interactive transurethral prostatic resection simulatorA Ballaro, T Briggs, F Garcia-Montes, et al.BJU International|June 26, 2003
Diagnostic accuracy of flow rate testing in urologyH R H Patel, F Garcia-Montes, N Christopher, et al.The Journal of Urology|November 13, 2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasiaV Watson, M Ryan, C T Brown, et al.Lasers in Surgery and Medicine|January 1, 1996
Alteration of laser-tissue interaction with the 805 nm diode laser using indocyanine green in the canine prostateH A Razvi, R Muschter, K Anson, et al.The British Journal of Radiology|January 19, 2012
Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent diseaseS Punwani, M Emberton, M Walkden, et al.Prostate Cancer and Prostatic Diseases|March 14, 2007
Point-of-care PSA testing: an evaluation of PSAwatchO Karim, A Rao, M Emberton, et al.BJU International|March 5, 2003
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?C T Brown, E O'Flynn, J Van Der Meulen, et al.World Journal of Urology|October 15, 2013
Role of focal salvage ablative therapy in localised radiorecurrent prostate cancerA Kanthabalan, M Arya, S Punwani, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 3, 2020
What to expect from a non-suspicious prostate MRI? A reviewG Fiard, J M Norris, T A Nguyen, et al.The Journal of Urology|January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once dailyR Hartung, H Matzkin, A Alcaraz, et al.Pageof 9